RestorGenex Corporation (OTCQB: RESX), a specialty biopharmaceutical company focused on developing products for ophthalmology, oncology, and dermatology, today announced that Stephen Simes, chief executive officer of RestorGenex, will present a corporate update at the Noble Financial Capital Markets’ Eleventh Annual Equity Conference at Club Med in Sandpiper Bay, Florida, on Tuesday, January 20, 2014 at 10:00 am Eastern Standard Time.
Help employers find you! Check out all the jobs and post your resume.
